ELANE and adrenal cortex carcinoma: To validate our DLK1 KO results, we assessed expression of NOTCH1 and NE proteins in ACC PDOs with high DLK1 expression (NCI-ACC40 and NCI-ACC48) and an ACC PDO with no DLK1 expression (NCI-ACC49) (Fig. 6G).